CompletedNot Applicable

Intravitreal Injection Site and Perceived Pain

United States53 participantsStarted 2022-11-14

Plain-language summary

The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 -100 years * Diagnosis of diabetic macular edema, age related macular degeneration, or retinal vein occlusion * Treated with bevacizumab, ranibizumab, aflibercept * The need for at least two intravitreal injections * Pseudophakia Exclusion Criteria: * Texas Department of Corrections medical records * Under 18 years-of-age * First intravitreal injection experience of patient

What they're measuring

Visual scale analogues for pain

Timeframe: Immediately post-injection

Trial details

NCT IDNCT05640895

SponsorThe University of Texas Medical Branch, Galveston

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-18

View on ClinicalTrials.gov More Pain trials